Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
China Biotechnology is Scopus-indexed (Q4, CiteScore 0.8). Published by China Biotechnology Press.
Checked against the index lists dated .
ISSN 1671-8135Verify ISSN ↗
Publisher: China Biotechnology Press
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Economics, Econometrics and Finance (miscellaneous) | 221 / 283 | 22nd | Q4 |
| Business, Management and Accounting (miscellaneous) | 186 / 235 | 21st | Q4 |
| Development | 260 / 314 | 17th | Q4 |
| Accounting | 164 / 191 | 14th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present, best quartile Q4, CiteScore 0.8.
China Biotechnology is Q4 in Economics, Econometrics and Finance (miscellaneous) (rank 221 of 283), Q4 in Business, Management and Accounting (miscellaneous) (rank 186 of 235) and Q4 in Development (rank 260 of 314), by CiteScore 2025. It is ranked in 4 subject areas in all.
China Biotechnology is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.8, quartile Q4, 22nd percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.140, quartile Q4, with an H-index of 7.
China Biotechnology is published by China Biotechnology Press. Its ISSN is 1671-8135.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
China Biotechnology has an h-index of 8 and a 2-year mean of 0 citations per paper (OpenAlex). Its Scopus CiteScore is 0.8, quartile Q4. On 2-year citations it ranks #254 of 274 Scopus journals in Economics, Econometrics and Finance (miscellaneous).
China Biotechnology published 112 papers in 2021; its busiest recent year was 2016 with 281. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.